Ryan J. Steel
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria.
Journal: Science (New York, N.Y.)
Published: August 13, 2026
Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling.
Journal: Science advances
Published: February 27, 2026
MK-7602: a potent multi-stage dual-targeting antimalarial.
Journal: EBioMedicine
Published: June 23, 2025
Protection from malaria infection using liver-targeted siRNA.
Journal: Molecular therapy. Methods & clinical development
Published: February 25, 2025
Flp/FRT-mediated disruption of ptex150 and exp2 in Plasmodium falciparum sporozoites inhibits liver-stage development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 05, 2024
Publisher Correction: Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission.
Publisher Correction: Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission.
Journal: Nature communications
Published: August 23, 2022
Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission.
Journal: Nature communications
Published: February 25, 2022
Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
Journal: Molecular & cellular proteomics : MCP
Published: June 19, 2021
Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity.
Journal: Bioorganic chemistry
Published: May 16, 2021
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
Journal: Cell host & microbe
Published: October 25, 2019
Last Updated: 09/26/2026